| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |